Tralokinumab
leo pharma
['derm', 'leopharma']
today at #eadvcongress, we re presenting new long-term safety data for the treatment of moderate-to-severe #atopicdermatitis.
Official account for #LEOPharma in the US. Please see our community guidelines here: https://t.co/gic59j37gx